Glenmark Pharma Signs Licensing Deal with Hengrui Pharma
Glenmark Pharmaceuticals’ subsidiary, Glenmark Specialty, has entered into an exclusive licensing agreement with Hengrui Pharma for Trastuzumab Rezetecan (SHR-A1811), a HER2-targeting antibody drug conjugate.
Newgen Software Bags €4.22 Million TCS Deal
Newgen Software Technologies’ subsidiary has signed a five-year Master Service Agreement with Tata Consultancy Services N.V., valued at €4,222,683 (approx. ₹44 crore).
Max India Issues Convertible Warrants Worth ₹80 Crore
Max India has allotted 36 lakh fully convertible warrants at an issue price of ₹222 per share, aggregating to ₹80 crore.
Kingfa India Raises ₹500 Crore via Share Allotment
Kingfa Science and Technology (India) approved the allotment of 14 lakh shares at ₹3,470 per share, raising nearly ₹500 crore.
TGV Sraac Expands Solar Power Capacity to 50.4 MW
TGV Sraac has added 5 MW solar power capacity, taking its total solar generation capacity to 50.4 MW.
Eimco Elecon Promoter to Exercise Oversubscription Option
Eimco Elecon (India) announced that its promoter, Tamrock Great Britain, will exercise an oversubscription option of up to 7 lakh shares.
Lupin Gets US FDA Tentative Nod for HIV Drug
Lupin has received tentative US FDA approval for its combination tablets containing Bictegravir, Emtricitabine & Tenofovir Alafenamide, used in the treatment of HIV infection in adults.
Ipca Labs Signs Tech Transfer Pact with Biosimilar Sciences USA
Ipca Laboratories has entered into a technology transfer agreement with Biosimilar Sciences USA for a monoclonal antibody biosimilar, strengthening Puerto Rico’s biotech ecosystem.
Sterlite Technologies Showcases New Optical Fibre Cable
Sterlite Technologies unveiled an advanced Unitube Single Jacket Indoor Optical Fibre Cable using Multi-Core Fiber (MCF) technology at Connected Britain 2025.
SMC Global Approves 1:1 Bonus Issue
SMC Global Securities’ board has approved the issuance of bonus shares in a 1:1 ratio.
Hubtown Converts Debentures into Shares
Hubtown has approved the conversion of 2.5 lakh compulsorily convertible debentures into an equal number of shares.
Quality Power Tools in Pact with Hyosung T&D India
Quality Power Tools’ subsidiary has signed an agreement with Hyosung T&D India for gas-insulated switchgear instrument transformers.
Allcargo Gati Case Reserved by NCLT
The NCLT has reserved orders in connection with the scheme of arrangement between Allcargo Logistics and its demerged subsidiaries.
Dalmia Bharat Faces ₹793 Crore PMLA Attachment
Dalmia Bharat’s subsidiary received an order from the adjudicating authority confirming a provisional attachment of ₹793.34 crore under the Prevention of Money Laundering Act.
Apollo Hospitals Gets CCI Nod for Scheme of Arrangement
The CCI has approved the proposed composite scheme involving Apollo Hospitals Enterprise, Apollo Healthco, and Keimed, with assets transferring to Apollo Healthtech.
REC Arm to Transfer Stake in Davanagere Power Transmission
REC’s subsidiary has signed a share purchase agreement to sell its entire stake in Davanagere Power Transmission to Power Grid.
Panacea Biotec Launches Baby Care and Infant Nutrition Products
Panacea Biotec has introduced two new domestic product lines — ‘NikoMom’ baby skin care range and ‘Staart Prime’ infant milk substitute (IMS).
Algoquant Fintech Infuses ₹1.3 Crore in Subsidiary
Algoquant Fintech will invest ₹1.3 crore in its arm, Algoquant Global Securities, via a rights issue.
Birla Corp Declared Preferred Bidder for Telangana Limestone Block
Birla Corporation’s subsidiary has been named the preferred bidder by the Telangana government for the Kanpa-Junapani limestone block auction.
Tata Steel Invests ₹4,054.7 Crore in Subsidiary
Tata Steel has acquired 457.7 crore shares of Tata Steel Holdings Pte, amounting to ₹4,054.7 crore.
TBO Tek Partners with Amadeus South Asia
TBO Tek has entered into a strategic partnership with Amadeus South Asia to develop an AI-driven travel platform.
NTPC Commissions Khurja STPP Unit II
NTPC subsidiary THDC India has commissioned Unit II of Khurja STPP, boosting NTPC Group’s total installed and commercial capacity to 83,696 MW.
Crisil to Acquire McKinsey PriceMetrix for $38 Million
Crisil has approved the acquisition of McKinsey PriceMetrix for $38 million, strengthening its financial analytics portfolio.
Wipro Restructures Subsidiaries for Simplicity
Wipro’s arm, Grove Holdings 2, has transferred its stake in Capco Consulting Middle East FZE to Wipro IT Services UK Societas, simplifying group structure.
Gujarat Pipavav Port Wins ONGC Contract
Gujarat Pipavav Port has secured a five-year contract from ONGC for port and storage facilities at Pipavav Port, effective October 1.
Veedol Launches Synthetic Engine Oil Range
Veedol Corporation has launched ‘SwiftPower’ and ‘SynthGlide’ fully synthetic engine oils for the domestic market, with plans to expand exports.
Torrent Pharma Issues ₹200 Crore Commercial Papers
Torrent Pharmaceuticals has issued unsecured commercial papers worth ₹200 crore with a 90-day tenure at 5.93% interest per annum.
Polycab Promoters to Sell Shares Worth ₹880 Crore
Polycab India promoters plan to sell 1.2 million shares worth ₹880 crore, with a floor price of ₹7,300, about 3% below CMP.
Power Grid Acquires Davanagere Power Transmission for ₹6.5 Crore
Power Grid Corporation of India has completed the acquisition of Davanagere Power Transmission for ₹6.5 crore under the TBCB route.
Insolation Energy Forms SPV for Solar Projects
Insolation Energy has incorporated a new arm, GNPR Green Infra, as a special purpose vehicle to set up solar power plants.
Aarti Drugs Distributed ₹278 Crore via Dividends and Buybacks
Over the past seven years, Aarti Drugs has returned nearly ₹278 crore to shareholders via dividends and buybacks, targeting 15–30% of consolidated net profits as distributions.
Disclaimer:
This article is intended solely for educational and informational purposes. The securities or companies mentioned are provided as examples and should not be considered as recommendations. Nothing contained herein constitutes personal financial advice or investment recommendations. Readers are advised to conduct their own research and consult a qualified financial advisor before making any investment decisions.
Investments in securities markets are subject to market risks. Please read all related documents carefully before investing.